SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-010081
Filing Date
2022-05-16
Accepted
2022-05-16 16:14:27
Documents
13
Period of Report
2022-05-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20220516.htm   iXBRL 8-K 61544
2 EX-99.1 crsp-ex99_1.htm EX-99.1 18098
  Complete submission text file 0000950170-22-010081.txt   199627

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20220516_pre.xml EX-101.PRE 10562
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20220516.xsd EX-101.SCH 2490
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20220516_lab.xml EX-101.LAB 12835
7 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20220516_htm.xml XML 4502
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 22929176
SIC: 2836 Biological Products, (No Diagnostic Substances)